Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-047382
Filing Date
2022-04-19
Accepted
2022-04-19 17:00:25
Documents
4
Period of Report
2022-04-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2212872d1_pre14a.htm PRE 14A 363525
2 GRAPHIC image_001.jpg GRAPHIC 1529
3 GRAPHIC tm2212872d1_pre14aimg001.jpg GRAPHIC 284881
4 GRAPHIC tm2212872d1_pre14aimg002.jpg GRAPHIC 197290
  Complete submission text file 0001104659-22-047382.txt   1031268
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36598 | Film No.: 22835503
SIC: 2834 Pharmaceutical Preparations